Vaccine Industry in India Expected to Rise at 13.4% CAGR during 2022-2027

According to a new report by IMARC titled “Indian Vaccine Market Report and Forecast 2022-2027”, The Indian vaccine market is expected to exhibit a CAGR of 13.4% during 2022-2027. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the market in any form.

A vaccine refers to a biological element that stimulates the production of antibodies against pathogens present in the body. It is generally created by using disease-causing agents and chemical drugs that act as antigens in illness prevention. Vaccines are mainly available in the form of a conjugate, inactivated, live attenuated, recombinant, subunit, and toxoid. They aid in preventing various life-threatening diseases, including polio, diphtheria, meningitis, influenza, measles, tetanus, rotavirus, hepatitis, etc. As a result, vaccines find widespread applications in several immunization procedures across clinics, hospitals, and vaccination centers and for research purposes in academic laboratories.

Request for a free sample copy of this report: https://www.imarcgroup.com/indian-vaccine-market/requestsample

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Indian Vaccine Market Trends and Drivers:

The escalating prevalence of various contagious diseases and the increasing consumer awareness towards adequate immunization for eradicating infections are among the primary factors driving the Indian vaccine market. Besides this, the launch of several policies by the government bodies to promote vaccination programs, especially across endemic regions, is further augmenting the market growth. Moreover, the development of new and improved vaccines by the leading pharmaceutical companies by accelerating the clinical trials of various pipeline drugs is also catalyzing the market across India. Apart from this, the rising number of child deaths, owing to several chronic diseases, such as hepatitis, polio, measles, rubella, etc., is acting as another significant growth-inducing factor. 

Additionally, the growing involvement of international organizations across the country, including WHO, UNICEF, World Bank, Bill & Melinda Gates Foundation, etc., in designing adequate vaccination facilities is also stimulating the market growth. Furthermore, the extensive research and development (R&D) activities to immunize various fatal conditions, such as AIDS, Ebola, Hepatitis C, paratyphoid fever, etc., are expected to bolster the Indian vaccine market in the coming years.

Market Summary:

• The market has been analyzed on the basis of various monovalent and combined vaccines into Bacillus Calmette-Guerin (BCG), Haemophilus influenzae type b (Hib), Influenza, Varicella, Typhoid, Japanese Encephalitis, Measles, Tetanus Toxoid, Hepatitis A, Rubella, Diphtheria, Tetanus and Pertussis (DPT), Oral Polio Vaccine (OPV), Measles, Mumps and Rubella (MMR), Rotavirus, Hepatitis B, Pneumococcal, Meningococcal, Rabies, Human Papillomavirus (HPV), Hexavalent and Dengue.
• The competitive landscape of the market has also been examined, with some of the key players being: GlaxoSmithKline PLC (GSK), Sanofi (SNY), Serum Institute of India, Panacea Biotec Limited., Pfizer, Inc. (PFE)., Novartis AG (NVS), VHB Life Sciences Limited, Cadila Healthcare Ltd. (Zydus Cadila) and Merck & Co., Inc. NYSE: MRK & Dohme Corporation (MSD).

Ask Analyst for 10% Free Customized Report: https://www.imarcgroup.com/request?type=report&id=554&flag=C

Note: We are updating our reports, if you want the report with the latest primary and secondary data (2023-2028) including industry trends, market size and competitive landscape, etc. click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800